Flexible Leadership, Lean Teams, and Phase 3 Execution: A Conversation with Leesa Gentry

In this episode of The Clinical Current, Leesa Gentry shares how RenovoRx is advancing innovation in interventional oncology while operating with a lean, highly focused clinical model. Drawing on decades of experience across pharma, biotech, and CRO environments, Leesa discusses what it really takes to run a Phase 3 program without a traditional global CRO, how COVID permanently reshaped site operations, and why technology and flexible leadership are now essential for trial execution. It’s a candid look at modern clinical operations in an era of tighter timelines, fewer resources, and higher expectations.